fenofibrate has been researched along with Asthma in 4 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, we showed that administration of 10 and 30 mg/kg fenofibrate effectively attenuated airway hyperresponsiveness and inflammation in a mouse model of allergic asthma, possibly through inhibition of NF-κB binding activity." | 8.31 | Fenofibrate attenuates asthma features in an ovalbumin-induced mouse model via suppressing NF-κB binding activity. ( Alhirmizi, IAO; Arslan, SO; Bayram, KK; Koç, A; Özünlü, SAÇ; Parlar, A; Uysal, F, 2023) |
| "In this study, we showed that administration of 10 and 30 mg/kg fenofibrate effectively attenuated airway hyperresponsiveness and inflammation in a mouse model of allergic asthma, possibly through inhibition of NF-κB binding activity." | 4.31 | Fenofibrate attenuates asthma features in an ovalbumin-induced mouse model via suppressing NF-κB binding activity. ( Alhirmizi, IAO; Arslan, SO; Bayram, KK; Koç, A; Özünlü, SAÇ; Parlar, A; Uysal, F, 2023) |
| "Treatment with fenofibrate (0." | 1.35 | Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate. ( Auwerx, J; Becker, J; Delayre-Orthez, C; Frossard, N; Pons, F, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhirmizi, IAO | 1 |
| Uysal, F | 1 |
| Arslan, SO | 1 |
| Özünlü, SAÇ | 1 |
| Koç, A | 1 |
| Parlar, A | 1 |
| Bayram, KK | 1 |
| Elaidy, SM | 1 |
| Essawy, SS | 1 |
| Hussain, MA | 1 |
| El-Kherbetawy, MK | 1 |
| Hamed, ER | 1 |
| Paw, M | 1 |
| Wnuk, D | 1 |
| Kądziołka, D | 1 |
| Sęk, A | 1 |
| Lasota, S | 1 |
| Czyż, J | 1 |
| Madeja, Z | 1 |
| Michalik, M | 1 |
| Delayre-Orthez, C | 1 |
| Becker, J | 1 |
| Auwerx, J | 1 |
| Frossard, N | 1 |
| Pons, F | 1 |
4 other studies available for fenofibrate and Asthma
| Article | Year |
|---|---|
Fenofibrate attenuates asthma features in an ovalbumin-induced mouse model via suppressing NF-κB binding activity.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, | 2023 |
Modulation of the IL-23/IL-17 axis by fenofibrate ameliorates the ovalbumin/lipopolysaccharide-induced airway inflammation and bronchial asthma in rats.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Cytokines; Fenofib | 2018 |
Fenofibrate Reduces the Asthma-Related Fibroblast-To-Myofibroblast Transition by TGF-Β/Smad2/3 Signaling Attenuation and Connexin 43-Dependent Phenotype Destabilization.
Topics: Asthma; Cell Proliferation; Cell Survival; Cells, Cultured; Connexin 43; Fenofibrate; Fibroblasts; H | 2018 |
Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Cytokines; Fenofibrate; Immunoglobulin E; Lipopolysacchar | 2008 |